Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Stacy Loeb MD

Stacy Loeb MD

Assistant Professor of Urology and Population Health, New York University

Dr. Stacy Loeb is an Assistant Professor of Urology and Population Health at New York University (NYU), specializing in prostate cancer. Dr. Loeb attended medical school at Northwestern University and completed her urology residency training at Johns Hopkins. She has published over 150 peer-reviewed articles and 8 book chapters on prostate cancer. She is on the Editorial Board for the British Journal of Urology International and Reviews in Urology, and authored the chapter on “Early Detection, Diagnosis, and Staging of Prostate Cancer” for Campbell-Walsh Urology. Dr. Loeb also helps teach several courses on prostate cancer for other urologists, and hosts the Men’s Health Show on Sirius XM 81 satellite radio.

Recent Contributions to PracticeUpdate:

  1. Regional Adoption of Commercial Gene Expression Testing for Prostate Cancer
  2. Twitter Mentions and Academic Citations in the Urologic Literature
  3. Prognostic Significance of a Negative Prostate Biopsy
  4. Lethal Prostate Cancer in the PLCO Cancer Screening Trial
  5. Histologic Grade Progression of PCa Common Even With Negative Confirmatory Biopsy
  6. Mortality and Complications After Prostate Biopsy in the PLCO Screening Trial
  7. Strategy for Detection of Prostate Cancer Based on Relation Between PSA at Age 40-55 and Long-Term Risk of Metastasis

Recently Updated